What is the long-term trend for Abbott's operating lease liability payments - 2027 (lessee)?

Over 3 years (2022 to 2025), Abbott's operating lease liability payments - 2027 (lessee) has grown at a 0.3% compound annual growth rate (CAGR), from $110.00M to $111.00M.

Discontinued — last reported Q3 '24

Non-Current Liabilities

Operating Lease Liability Payments - 2027 (Lessee)

Abbott Operating Lease Liability Payments - 2027 (Lessee) increased by 7.8% to $111.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Operating Lease Liability Payments - 2027 (Lessee) shows relatively stable performance with a 0.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Liabilities

First reportedQ1 2020

Last reportedQ3 2024

Metric ID: lease_liability_payments_2027_lessee

Historical Data

4 periods

	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$110.00M	$110.00M	$103.00M	$111.00M
QoQ Change	—	+0.0%	-6.4%	+7.8%
YoY Change	—	+0.0%	-6.4%	+7.8%

Range$103.00M – $111.00M

Avg YoY Growth+0.5%

Median YoY Growth+0.0%

Operating Lease Liability Payments - 2027 (Lessee) at Other Companies

West Pharmaceutical ServicesWST View metric

Idexx LaboratoriesIDXX View metric

Frequently Asked Questions

What is Abbott's operating lease liability payments - 2027 (lessee)?: Abbott (ABT) reported operating lease liability payments - 2027 (lessee) of $111.00M in Q4 2025.
What is the long-term trend for Abbott's operating lease liability payments - 2027 (lessee)?: Over 3 years (2022 to 2025), Abbott's operating lease liability payments - 2027 (lessee) has grown at a 0.3% compound annual growth rate (CAGR), from $110.00M to $111.00M.